AI/ML Innovations’ Tech2Heal Wins Prestigious Innovation Grand Prize Award - Seite 2

Alakin has highly configurable features and an integrated series of tools unique in the market, such as scheduling management, collaborative tools, embedded telemedicine and chat, a triage dashboard, patient records, a prescription builder, a care pathways studio, and a mobile app for patients.

Foto: Accesswire

About Tech2Heal https://www.tech2heal.com/

Tech2Heal is a Paris, France based healthcare innovator specializing in digital health technologies with the objective of creating a compassionate, collaborative and patient-centered healthcare ecosystem. T2H has developed a portfolio of health-tech products and services designed to improve an individual's mental and physical well-being by utilizing a unique blend of proprietary digital assets and remote live counselling.

Tech2Heal's premier products include:

Qookka - clinically supported and evidence-based digital therapy for anxious and depressed patients delivered via a secure digital platform

Alakin - a bespoke, digital ARPC (Automatic Remote Patient Care) Platform designed for healthcare providers and pharma. Assisted self-care become reality for patients and care team members alike.

Foto: Accesswire

About AI/ML Innovations Inc. https://aiml-innovations.com/

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (100% owned by AIML), Tech2Heal (up to 22% ownership rights, with 9.44% currently owned), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".